Get started
Author

Małgorzata Krawczyk‐Kuliś

Observed names: M Krawczyk-Kulis, M Krawczyk-Kuliś, M. Krawczyk-Kulis, M. Krawczyk-Kuliś, Malgorzata Krawczyk-Kulis, Malgorzata Krawczyk-kulis, Malgorzata Krawczyk‐Kulis, Małgorzata Krawczyk-Kulis, Małgorzata Krawczyk-Kuliś, Małgorzata Krawczyk‐Kulis, Małgorzata Krawczyk‑Kuliś
OpenAlex ID: A5076988498
Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study
2008 · Jerzy Holowiecki, Malgorzata Krawczyk‐Kulis, et al. · British Journal of Haematology · 142
PDF
2-Chlorodeoxyadenosine (2-CdA) in 2-Hour Versus 24-Hour Intravenous Infusion in the Treatment of Patients with Hairy Cell Leukemia
1996 · T. Robak, M. Blasinska-Morawiec, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 68
Use of L‑asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group
2008 · Beata Piątkowska‑Jakubas, Małgorzata Krawczyk‑Kuliś, et al. · Polskie Archiwum Medycyny Wewnętrznej · 60
PDF
Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL
2009 · S Giebel, B Stella-Holowiecka, et al. · Bone Marrow Transplantation · 59
Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma
2019 · Maroulio Pertesi, Maxime Vallée, et al. · Leukemia · 48
Activating killer immunoglobulin‐like receptor incompatibilities enhance graft‐versus‐host disease and affect survival after allogeneic hematopoietic stem cell transplantation
2009 · Sebastian Giebel, Izabela Nowak, et al. · European Journal Of Haematology · 37
Association of KIR2DS4 and its variant KIR1D with leukemia
2008 · S Giebel, I Nowak, et al. · Leukemia · 36
Impact of Activating Killer Immunoglobulin-like Receptor Genotype on Outcome of Unrelated Donor–Hematopoietic Cell Transplantation
2006 · S. Giebel, I. Nowak, et al. · Transplantation Proceedings · 35
G-CSF Administered in Time-sequenced Setting During Remission Induction and Consolidation Therapy of Adult Acute Lymphoblastic Leukemia has Beneficial Influence on Early Recovery and Possibly Improves Long-term Outcome: A Randomized Multicenter Study
2002 · Jerzy Hołowiecki, Sebastian Giebel, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 32
Homozygosity for human leucocyte antigen‐C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen‐C‐matched unrelated donor haematopoietic stem cell transplantation
2005 · Sebastian Giebel, Franco Locatelli, et al. · British Journal of Haematology · 31
Treosulfan and fludarabine low‐toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia
2008 · Jerzy Holowiecki, Sebastian Giebel, et al. · British Journal of Haematology · 30
Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG)
2006 · Sebastian Giebel, Malgorzata Krawczyk-Kulis, et al. · Annals of Hematology · 29
Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
2005 · Grzegorz Helbig, Beata Stella-Holowiecka, et al. · PubMed · 28
Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT
2010 · S Giebel, J Dziaczkowska, et al. · Bone Marrow Transplantation · 26
Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years
2009 · Sebastian Giebel, Myriam Labopin, et al. · Annals of Hematology · 24
Acute graft-versus-host disease. The incidence and risk factors.
2006 · Jerzy Wojnar, Sebastian Giebel, et al. · PubMed · 18
Identification of miRSNPs associated with the risk of multiple myeloma
2016 · Angelica Macauda, Diego Calvetti, et al. · International Journal of Cancer · 12
PDF
The impact of immunosuppressive therapy on an early quantitative NK cell reconstitution after allogeneic haematopoietic cell transplantation.
2005 · Sebastian Giebel, Joanna Dziaczkowska, et al. · PubMed · 11
Stem cell mobilization in multiple myeloma patients relapsing after previous autologous hematopoietic stem cell transplantation: A multicenter report by the Polish Myeloma Study Group
2021 · Joanna Drozd‐Sokołowska, Anna Waszczuk‐Gajda, et al. · Journal of Clinical Apheresis · 10
Cereblon (CRBN) gene polymorphisms predict clinical response and progression-free survival in relapsed/refractory multiple myeloma patients treated with lenalidomide: a pharmacogenetic study from the IMMEnSE consortium
2019 · Elżbieta Iskierka-Jażdżewska, Federico Canzian, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
The incidence and risk factors for chronic graft-versus-host-disease.
2006 · Jerzy Wojnar, Sebastian Giebel, et al. · PubMed · 10
Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients
2000 · J. Hołowiecki, M. Wojciechowska, et al. · Transplantation Proceedings · 9
The importance of the number of transplanted cells with dipeptidyl peptidase‐4 expression on the haematopoietic recovery and lymphocyte reconstitution in patients with multiple myeloma after autologous haematopoietic stem‐cell transplantation
2015 · Anna Kopinska, Małgorzata Krawczyk‐Kulis, et al. · Hematological Oncology · 8
Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis
2015 · Sławomira Kyrcz-Krzemień, Grzegorz Helbig, et al. · Hematology · 8
PDF
Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia.
2006 · Sebastian Giebel, Jerzy Wojnar, et al. · PubMed · 8
Works count: 146
Citation count: 915
H-index: 16
I10-index: 21
Year
Topic
Type